DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel ...

An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow bacteria to build resistance to drugs.

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

EBP1 is low in Alzheimer’s disease brains, hinting at human relevance. “Our study suggests that … preservation of functional EBP1 could be a therapeutic strategy for AD,” the authors noted. The ...

Trial aims to establish safety and provide proof of concept for GYS1 inhibition as promising new treatment strategy in patients with late-onset Pompe disease ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

Spending enough time in the sun without adequate protection can leave us looking and presumably feeling like a lobster ready ...

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

DNA-nanoparticle motors are exactly as they sound: tiny artificial motors that use the structures of DNA and RNA to propel ...

Researchers engineered a DNA-nanoparticle motor achieving 30 nm/s speed, enhancing performance to rival natural motor ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...